Hyperleukocytosis Emergency: Risk depends on blast size and deformability. AML blasts are large and rigid (high risk > 100), while Lymphoblasts are smaller (high risk > 400).
1. Select Diagnosis
2. Entrance Count
WBC (×10^9/L)
Enter count to assess
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Evaluating patients with Hyperleukocytosis (WBC > 100 × 10⁹/L) for signs and symptoms of leucostasis.
Triage of Acute Myeloid Leukemia (AML) vs. Acute Lymphoblastic Leukemia (ALL) based on risk thresholds.
Guiding the necessity for urgent cytoreduction or leukapheresis.
Pathophysiology
Leucostasis occurs when high concentrations of large, non-deformable blasts increase blood viscosity and cause endothelial damage and local hypoxia in the microvasculature.
Section 2
Formula & Logic
WBC (× 10⁹/L) Risk Levels
Diagnosis
High Risk Threshold
Clinical Context
AML
> 100
High risk; large, sticky blasts cause stasis easily.
ALL
> 400
Lower risk; small lymphoblasts are more deformable.
CML (Chronic)
> 500
Very low risk; mature cells are small and deformable.
The 'Sick' Organ Signs
Pulmonary: Dyspnea, tachypnea, "white out" on CXR (low sensitivity).
In extreme hyperleukocytosis, ABG samples can show "pseudohypoxemia" because the high concentration of metabolically active WBCs consumes the dissolved oxygen in the test tube. Always rely on Pulse Oximetry (SpO₂) in these cases.
Cytoreduction Timing
Leucostasis is a medical emergency. Start aggressive hydration and Hydroxyurea (50–100 mg/kg/day) immediately. Allopurinol or Rasburicase is strictly required to prevent secondary Tumor Lysis Syndrome.
Section 4
Evidence Appraisal
Primary Consensus
How I treat hyperleukocytosis in acute myeloid leukemia.